Page last updated: 2024-09-04

sk&f 83959 and spiperone

sk&f 83959 has been researched along with spiperone in 2 studies

Compound Research Comparison

Studies
(sk&f 83959)
Trials
(sk&f 83959)
Recent Studies (post-2010)
(sk&f 83959)
Studies
(spiperone)
Trials
(spiperone)
Recent Studies (post-2010) (spiperone)
940462,9441385

Protein Interaction Comparison

ProteinTaxonomysk&f 83959 (IC50)spiperone (IC50)
Bile salt export pumpHomo sapiens (human)10
D(2) dopamine receptorHomo sapiens (human)0.0008
Alpha-1B adrenergic receptorRattus norvegicus (Norway rat)0.097
D(4) dopamine receptorHomo sapiens (human)0.0005
Alpha-1D adrenergic receptorRattus norvegicus (Norway rat)0.097
Histamine H1 receptorCavia porcellus (domestic guinea pig)0.097
D(3) dopamine receptorHomo sapiens (human)0.0635
Alpha-1A adrenergic receptorRattus norvegicus (Norway rat)0.097
D(2) dopamine receptorRattus norvegicus (Norway rat)0.0001
Sigma non-opioid intracellular receptor 1Homo sapiens (human)0.955

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Deveney, AM; Waddington, JL1
Chen, J; Ma, L; Wang, F; Zhang, H; Zhen, X1

Other Studies

2 other study(ies) available for sk&f 83959 and spiperone

ArticleYear
Pharmacological characterization of behavioural responses to SK&F 83959 in relation to 'D1-like' dopamine receptors not linked to adenylyl cyclase.
    British journal of pharmacology, 1995, Volume: 116, Issue:3

    Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Adenylyl Cyclases; Animals; Behavior, Animal; Benzamides; Benzazepines; Binding, Competitive; Chromans; Dopamine Agonists; Dopamine Antagonists; Enzyme Induction; Isoquinolines; Male; Radioligand Assay; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1; Spiperone; Tetrahydroisoquinolines

1995
Chronic SKF83959 induced less severe dyskinesia and attenuated L-DOPA-induced dyskinesia in 6-OHDA-lesioned rat model of Parkinson's disease.
    Neuropharmacology, 2007, Volume: 53, Issue:1

    Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Analysis of Variance; Animals; Disease Models, Animal; Dopamine Agonists; Dopamine Antagonists; Drug Administration Schedule; Drug Interactions; Dyskinesia, Drug-Induced; Levodopa; Male; Movement; Oxidopamine; Parkinson Disease; Proto-Oncogene Proteins c-fos; Rats; Rats, Sprague-Dawley; Serotonin Antagonists; Spiperone; Sympatholytics; Time Factors

2007